<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36811824</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2210-6014</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of epidemiology and global health</Title><ISOAbbreviation>J Epidemiol Glob Health</ISOAbbreviation></Journal><ArticleTitle>Age of First Overweight and Obesity, COVID-19 and Long COVID in Two British Birth Cohorts.</ArticleTitle><Pagination><StartPage>140</StartPage><EndPage>153</EndPage><MedlinePgn>140-153</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s44197-023-00093-5</ELocationID><Abstract><AbstractText>Longer exposure to obesity, and thus a longer period in an inflamed state, may increase susceptibility to infectious diseases and worsen severity. Previous cross-sectional work finds higher BMI is related to worse COVID-19 outcomes, but less is known about associations with BMI across adulthood. To examine this, we used body mass index (BMI) collected through adulthood in the 1958 National Child Development Study (NCDS) and the 1970 British Cohort Study (BCS70). Participants were grouped by the age they were first overweight (&gt;&#x2009;25&#xa0;kg/m<sup>2</sup>) and obese (&gt;&#x2009;30&#xa0;kg/m<sup>2</sup>). Logistic regression was used to assess associations with COVID-19 (self-reported and serology-confirmed), severity (hospital admission and contact with health services) and long-COVID reported at ages 62 (NCDS) and 50 (BCS70). An earlier age of obesity and overweight, compared to those who never became obese or overweight, was associated with increased odds of adverse COVID-19 outcomes, but results were mixed and often underpowered. Those with early exposure to obesity were over twice as likely in NCDS (odds ratio (OR) 2.15, 95% confidence interval (CI) 1.17-4.00) and three times as likely in BCS70 (OR 3.01, 95% CI 1.74-5.22) to have long COVID. In NCDS they were also over four times as likely to be admitted to hospital (OR 4.69, 95% CI 1.64-13.39). Most associations were somewhat explained by contemporaneous BMI or reported health, diabetes or hypertension; however, the association with hospital admission in NCDS remained. An earlier age of obesity onset is related to COVID-19 outcomes in later life, providing evidence of the long-term impact of raised BMI on infectious disease outcomes in midlife.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bridger Staatz</LastName><ForeName>Charis</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2872-6968</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK. charis.staatz.17@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bann</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6454-626X</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ploubidis</LastName><ForeName>George B</ForeName><Initials>GB</Initials><Identifier Source="ORCID">0000-0002-8198-5790</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Alissa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverwood</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-2744-1194</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/V002147/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P023444/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>COV-LT-0009-28654</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Epidemiol Glob Health</MedlineTA><NlmUniqueID>101592084</NlmUniqueID><ISSNLinking>2210-6006</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="Y">Overweight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089822" MajorTopicYN="N">Birth Cohort</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 severity</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Longitudinal</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>16</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36811824</ArticleId><ArticleId IdType="pmc">PMC9945825</ArticleId><ArticleId IdType="doi">10.1007/s44197-023-00093-5</ArticleId><ArticleId IdType="pii">10.1007/s44197-023-00093-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nishiga M, et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543&#x2013;558. doi: 10.1038/s41569-020-0413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dowc A. Covid-19: Third of people infected have long term symptoms. Bmj Br Med J. 2021;373:n1626. doi: 10.1136/bmj.n1626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1626</ArticleId><ArticleId IdType="pubmed">34168002</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health And Care Excellence . COVID-19 rapid evidence review: signs, symptoms and prevalence. London: NICE; 2021.</Citation></Reference><Reference><Citation>Thompson EJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmels JPW, Meneses-Echavez JF, Brurberg KG. Post COVID-19 condition and new onset diseases after COVID-19. Oslo: Norwegian Institute of Public Health; 2022.</Citation></Reference><Reference><Citation>Bosworth M, Pawelek P, Ayoubkhani D (2023) Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 5 January 2023, in Statistical bulletin, Office for National Statistics. Statistics, Editor. 2023: Office for National Statistics https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/5january2023</Citation></Reference><Reference><Citation>National Institute for Health And Care Excellence (2021) COVID-19 rapid guideline: managing the long-term effects of COVID-19&#x2014;NICE, RCGP, and SIGN. Available from: https://www.nice.org.uk/guidance/ng188. Accessed May 23 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation (2021) Obesity and Overweight. WHO fact-sheets. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed May 23 2022</Citation></Reference><Reference><Citation>Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752&#x2013;1770. doi: 10.1161/CIRCRESAHA.115.306883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306883</ArticleId><ArticleId IdType="pubmed">27230640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zammit C, et al. Obesity and respiratory diseases. Int J Gen Med. 2010;3:335&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2990395</ArticleId><ArticleId IdType="pubmed">21116339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelishadi R, et al. Association of childhood obesity and the immune system: a systematic review of reviews. Child Obes. 2017;13(4):332&#x2013;346. doi: 10.1089/chi.2016.0176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/chi.2016.0176</ArticleId><ArticleId IdType="pubmed">28604080</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates T, et al. Obesity and risk of COVID-19: analysis of UK biobank. Prim Care Diabetes. 2020;14(5):566&#x2013;567. doi: 10.1016/j.pcd.2020.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2020.05.011</ArticleId><ArticleId IdType="pmc">PMC7254007</ArticleId><ArticleId IdType="pubmed">32493608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1149&#x2013;1151. doi: 10.1016/j.dsx.2020.06.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.060</ArticleId><ArticleId IdType="pmc">PMC7326434</ArticleId><ArticleId IdType="pubmed">32668401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawadogo W, et al. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis. BMJ Nutr Prev Health. 2022 doi: 10.1136/bmjnph-2021-000375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2021-000375</ArticleId><ArticleId IdType="pmc">PMC8783972</ArticleId><ArticleId IdType="pubmed">35814718</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverwood RJ, et al. Association between younger age when first overweight and increased risk for CKD. J Am Soc Nephrol. 2013;24(5):813&#x2013;821. doi: 10.1681/ASN.2012070675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2012070675</ArticleId><ArticleId IdType="pmc">PMC3636792</ArticleId><ArticleId IdType="pubmed">23559581</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MT, et al. Life-course trajectories of body mass index and subsequent cardiovascular risk among Chinese population. PLoS ONE. 2019;14(10):e0223778. doi: 10.1371/journal.pone.0223778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223778</ArticleId><ArticleId IdType="pmc">PMC6786833</ArticleId><ArticleId IdType="pubmed">31600353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AK, et al. Trajectories of overweight and body mass index in adulthood and blood pressure at age 53: the 1946 British birth cohort study. J Hypertens. 2010;28(4):679&#x2013;686. doi: 10.1097/HJH.0b013e328335de7b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e328335de7b</ArticleId><ArticleId IdType="pubmed">20042875</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris T, et al. Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: a cohort study. Plos Med. 2020;17(12):e1003387. doi: 10.1371/journal.pmed.1003387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003387</ArticleId><ArticleId IdType="pmc">PMC7723271</ArticleId><ArticleId IdType="pubmed">33290405</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Association of weight change patterns across adulthood with incident asthma: a retrospective cohort study. Sci Rep. 2022;12(1):9756. doi: 10.1038/s41598-022-13555-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13555-w</ArticleId><ArticleId IdType="pmc">PMC9192600</ArticleId><ArticleId IdType="pubmed">35697748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng CD, Cunningham SA. In, out, and fluctuating: obesity from adolescence to adulthood. Ann Epidemiol. 2020;41:14&#x2013;20. doi: 10.1016/j.annepidem.2019.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2019.12.003</ArticleId><ArticleId IdType="pmc">PMC7024010</ArticleId><ArticleId IdType="pubmed">31901410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellulu MS, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851&#x2013;863. doi: 10.5114/aoms.2016.58928.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2016.58928</ArticleId><ArticleId IdType="pmc">PMC5507106</ArticleId><ArticleId IdType="pubmed">28721154</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro AM, Macedo-de la Concha LE, Pantoja-Mel&#xe9;ndez CA. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Rev Med Hosp Gen M&#xe9;x. 2017;80(2):101&#x2013;105.</Citation></Reference><Reference><Citation>Gallo Marin B, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1&#x2013;10. doi: 10.1002/rmv.2146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2146</ArticleId><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gondek D. We are living longer, but not healthier: evidence from the British birth cohorts and the Uppsala Birth Cohort multigenerational study, in department of social science. London: University College London; 2020.</Citation></Reference><Reference><Citation>Norris T, et al. Changes over time in latent patterns of childhood-to-adulthood BMI development in Great Britain: evidence from three cohorts born in 1946, 1958, and 1970. Bmc Med. 2021 doi: 10.1186/s12916-021-01969-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01969-8</ArticleId><ArticleId IdType="pmc">PMC8059270</ArticleId><ArticleId IdType="pubmed">33879138</ArticleId></ArticleIdList></Reference><Reference><Citation>Power C, Elliott J. Cohort profile: 1958 British birth cohort (national child development study) Int J Epidemiol. 2006;35(1):34&#x2013;41. doi: 10.1093/ije/dyi183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyi183</ArticleId><ArticleId IdType="pubmed">16155052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan A, et al. Cohort profile update: the 1970 British cohort study (BCS70) Int J Epidemiol. 2022 doi: 10.1093/ije/dyac148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac148</ArticleId><ArticleId IdType="pmc">PMC10244059</ArticleId><ArticleId IdType="pubmed">35849349</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M, Goodman A, Peters A, Ploubidis GB, Sanchez A, Silverwood R, Smith K. COVID-19 survey in five national longitudinal studies: waves 1 2 and 3 user guide (version 3) London: UCL Centre for Longi-tudinal Studies and MRC Unit for Lifelong Health and Ageing; 2021.</Citation></Reference><Reference><Citation>Matt Brown AP, Ploubidis GB, Sanchez A, Silverwood RJ. COVID-19 antibody testing in the national child development study, 1970 British cohort study, next steps and millennium cohort study: user guide (version 1) London: UCL Centre for Longitudinal Studies; 2021.</Citation></Reference><Reference><Citation>Riester E, et al. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay. J Virol Methods. 2021;297:114271. doi: 10.1016/j.jviromet.2021.114271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114271</ArticleId><ArticleId IdType="pmc">PMC8393518</ArticleId><ArticleId IdType="pubmed">34461153</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren L. Socioeconomic status and obesity. Epidemiol Rev. 2007;29:29&#x2013;48. doi: 10.1093/epirev/mxm001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/epirev/mxm001</ArticleId><ArticleId IdType="pubmed">17478442</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanijahani A, et al. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health. 2021;20(1):248. doi: 10.1186/s12939-021-01582-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01582-4</ArticleId><ArticleId IdType="pmc">PMC8611382</ArticleId><ArticleId IdType="pubmed">34819081</ArticleId></ArticleIdList></Reference><Reference><Citation>Deary IJ, Hill WD, Gale CR. Intelligence, health and death. Nat Hum Behav. 2021;5(4):416&#x2013;430. doi: 10.1038/s41562-021-01078-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01078-9</ArticleId><ArticleId IdType="pubmed">33795857</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581&#x2013;590. doi: 10.1093/biomet/63.3.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/63.3.581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa T, Wiggins RD (2014) Handling attrition and non-response in the 1970 British Cohort Study, in CLS Working Paper. Centre for Longitudinal Studies</Citation></Reference><Reference><Citation>Mostafa T, et al. Missing at random assumption made more plausible: evidence from the 1958 British birth cohort. J Clin Epidemiol. 2021;136:44&#x2013;54. doi: 10.1016/j.jclinepi.2021.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.02.019</ArticleId><ArticleId IdType="pubmed">33652080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011;305(8):822&#x2013;823. doi: 10.1001/jama.2011.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.163</ArticleId><ArticleId IdType="pmc">PMC4115579</ArticleId><ArticleId IdType="pubmed">21343582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, et al. Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9(6):350&#x2013;359. doi: 10.1016/S2213-8587(21)00089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00089-9</ArticleId><ArticleId IdType="pmc">PMC8081400</ArticleId><ArticleId IdType="pubmed">33932335</ArticleId></ArticleIdList></Reference><Reference><Citation>de Frel DL, et al. The Impact of obesity and lifestyle on the immune system and susceptibility to infections such as COVID-19. Front Nutr. 2020 doi: 10.3389/fnut.2020.597600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2020.597600</ArticleId><ArticleId IdType="pmc">PMC7711810</ArticleId><ArticleId IdType="pubmed">33330597</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JA, et al. Poverty, inequality and COVID-19: the forgotten vulnerable. Public Health. 2020;183:110&#x2013;111. doi: 10.1016/j.puhe.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7221360</ArticleId><ArticleId IdType="pubmed">32502699</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>